Roche Abandons New Diabetes Drug

Development of the drug, aleglitazar, was discontinued after Roche cited safety reasons and questions over its effectiveness.

    

Powered by WPeMatico

Share
This entry was posted in World News. Bookmark the permalink.

Comments are closed.